These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9929036)

  • 1. Male contraceptive research steps back into spotlight.
    Bonn D
    Lancet; 1999 Jan; 353(9149):302. PubMed ID: 9929036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal male contraception: progress and prospects for the 21st century.
    Handelsman DJ
    Aust N Z J Med; 1995 Dec; 25(6):808-16. PubMed ID: 8770357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in research into new methods of fertility regulation for men.
    Prog Hum Reprod Res; 1995; (33):2. PubMed ID: 12289975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress and prospects in male hormonal contraception.
    Amory JK
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):255-60. PubMed ID: 18438174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
    Anderson RA; Wallace AM; Wu FC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations.
    Kamischke A; Heuermann T; Krüger K; von Eckardstein S; Schellschmidt I; Rübig A; Nieschlag E
    J Clin Endocrinol Metab; 2002 Feb; 87(2):530-9. PubMed ID: 11836281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug insight: Recent advances in male hormonal contraception.
    Amory JK; Page ST; Bremner WJ
    Nat Clin Pract Endocrinol Metab; 2006 Jan; 2(1):32-41. PubMed ID: 16932251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial.
    Anawalt BD; Amory JK; Herbst KL; Coviello AD; Page ST; Bremner WJ; Matsumoto AM
    J Androl; 2005; 26(3):405-13. PubMed ID: 15867009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New male contraceptive entering clinical trials worldwide.
    Contracept Technol Update; 1989 Oct; 10(10):142-3. PubMed ID: 12342588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A non-human primate study (baboon; Papio hamadryas) to determine if a long-acting progestogen, levonorgestrel butanoate, combined with a long-acting androgen, testosterone buciclate, can suppress spermatogenesis: I. Dose-finding study.
    Goncharov NP; Katzia GV; Butnev VU; Richkor EG; Matikainen T; Waites GM
    Int J Androl; 1995 Apr; 18(2):75-82. PubMed ID: 7665213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
    Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
    J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bridging the gender gap in contraception: another hurdle cleared.
    Handelsman DJ
    Med J Aust; 1991 Feb; 154(4):230-3. PubMed ID: 1994193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contraceptive developments for men.
    Amory JK
    Drugs Today (Barc); 2007 Mar; 43(3):179-92. PubMed ID: 17380214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception.
    Kamischke A; Venherm S; Plöger D; von Eckardstein S; Nieschlag E
    J Clin Endocrinol Metab; 2001 Jan; 86(1):303-9. PubMed ID: 11232016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Australian scientists develop male contraceptive.
    JAMA; 1974 May; 228(8):1043. PubMed ID: 12333267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraceptive potential of analogs of LH-RH.
    Schally AV
    Netw Res Triangle Park N C; 1984; 6(1):7-8. PubMed ID: 12266403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.